Yew Bio Pharm Cash Flow - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.28 $0 (0%) YEWB stock closing price Oct 20, 2016 (Closing)

The cash flow statement is one of the reports a publicly traded company like Yew Bio Pharm needs to disclose. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Yew Bio Pharm profits and Yew Bio Pharm debt. Yew Bio Pharm stock analysis shows positive net income cash flow of $2.35M for 2016-Q2. This statement is important because profits alone cannot pay employees, or bills. Cash is required. View details of Yew Bio Pharm cash flows for latest & last 40 quarters.

show more
Get Cash flow for another ticker
Fiscal year is Jan - Dec. 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Yew Bio Pharm Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow8.87M5.02M7.74M1.22M0.33M0.16M0.68M0.51M0.34M0.17M
Net Increase (Decrease) in Assets Liabilities-11.16M-6.57M-15.43M-7.09M-5.41M-1.78M-1.35M-1.03M-0.28M-1.13M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.16M0.08M1.03M0.77M0.55M0.3M0.5M0.32M--
Yew Bio Pharm Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment---0.02M-1.37M-0.59M---4.5M-3.75M0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities---2.33M----2.44M---0.05M
Yew Bio Pharm Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares----------
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings--3.21M1.64M1.64M-----
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.03M-0.02M0.74M0.65M0.65M--2.33M-0.02M-0.02M-1.42M
Yew Bio Pharm Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.01M--0.03M-0.03M---0.01M-0.01M-0.01M-
Yew Bio Pharm Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year0.48M1.15M0.38M0.73M1.85M-----
Cash & Equivalents at Year End0.84M0.23M0.68M0.17M0.61M0.12M0.48M0.12M0.23M0.09M
All figures in USD. M: Millions of USD, B: Billions of USD.

While Yew Bio Pharm stock price history provides the price history of a stock, Yew Bio Pharm stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:
  • Yew Bio Pharm has cash of $0.84M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Yew Bio Pharm stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $0.22M for YEWB. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between Yew Bio Pharm and its owners and creditors and was $-0.03M for 2016-Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Yew Bio Pharm Cash Flow

FCF margin